Testosterone propionate, sold under the brand name Testoviron among others, is an androgen and anabolic steroid (AAS) drug which is utilized fundamentally in the therapy of low testosterone levels in men. It has additionally been utilized to treat bosom disease in women. It is given by infusion into muscle for the most part once every a few days.
Results of testosterone propionate incorporate side effects of masculinization like skin break out, expanded hair development, voice changes, and expanded sexual desire. The medication is a manufactured androgen and anabolic steroid and thus is an agonist of the androgen receptor (AR), the organic objective of androgens like testosterone and dihydrotestosterone (DHT). It makes solid androgenic impacts and moderate anabolic impacts, which make it valuable for creating masculinization and reasonable for androgen substitution therapy. Testosterone propionate is a testosterone ester and a generally short-acting prodrug of testosterone in the body. Along these lines, it is viewed as a characteristic and bioidentical type of testosterone.
Testosterone propionate was found in 1936 and was presented for clinical use in 1937. It was the primary testosterone ester to be promoted, and was the significant type of testosterone utilized in medication until around 1960. The presentation of longer-acting testosterone esters like testosterone enanthate, testosterone cypionate, and testosterone undecanoate beginning during the 1950s brought about testosterone propionate for the most part being superseded. Thusly, it is seldom utilized today notwithstanding its clinical use, testosterone propionate is utilized to further develop body and performance. The medication is a controlled substance in numerous nations thus non-clinical use is by and large illegal.